Clinical Trial

Fluid Intolerance Signals as Safety Limits to Prevent Fluid-induced Harm During Septic Shock Resuscitation

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 2, 2024 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this multicentric randomized controlled trial is to compare, in septic shock patients who require further fluid resuscitation, two strategies of administering fluids. The intervention group will integrate fluid intolerance signals to the decision making process, while the control group will follow standard of care, for a 6 hour study protocol. The main question it aims to answer is 1. To compare the effect of both resuscitation strategies on fluid-induced harm, assessed by the change in pulmonary, cardiac, and renal function biomarkers during the study period. 2. To assess the safety of both resuscitation strategies on hypoperfusion resolution, measured by the improvement of capillary refill time (CRT) and lactate during the study period. 3. To determine the dynamics of the different fluid intolerance signals
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-21.
Status change: Not Yet Recruiting → Recruiting 2024-09-30
Trial Details
NCT Number NCT06568744
Lead Sponsor Pontificia Universidad Catolica de Chile
Conditions Septic Shock
Enrollment 62 participants
Start Date 2024-08-22
Primary Completion 2026-05 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-10-02